The brain cancer diagnostics market is projected to reach US$ 7,378.57 Million by 2028 from US$ 1,639.10 Million in 2022; it is estimated to grow at a CAGR of 28.5% from 2022 to 2028.
Brain cancers are caused due to extracellular growth of the cells in the brain that causes tumors. The tumor includes primary brain tumors and secondary brain tumors. Primary brain tumors are formed in the brain and do not spread to other body parts, whereas secondary tumors, also known as metastases, are those cancers that began in another part of the body. Brain tumors are categorized into 40 major types that are further classified into two major groups, including benign, i.e., slow-growing and have less possibility to spread, and malignant, i.e., cancerous, and more likely to spread.
The brain cancer diagnostics market is segmented into diagnostic type, cancer type, end user, tumor size, and geography. The market , by geography, is broadly segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South and Central America. The report offers in-depth insights into the market, emphasizing parameters such as market trends, technological advancements, and market dynamics, along with an analysis of the competitive landscape of leading market players.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Brain Cancer Diagnostics Market: Strategic Insights
Market Size Value in US$ 1,639.10 Million in 2022 Market Size Value by US$ 7,378.57 Million by 2028 Growth rate CAGR of 28.5% from 2022 to 2028. Forecast Period 2022-2028 Base Year 2022
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Brain Cancer Diagnostics Market: Strategic Insights
| Market Size Value in | US$ 1,639.10 Million in 2022 |
| Market Size Value by | US$ 7,378.57 Million by 2028 |
| Growth rate | CAGR of 28.5% from 2022 to 2028. |
| Forecast Period | 2022-2028 |
| Base Year | 2022 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Market Insights
Rising Incidences of Brain Tumors Contributes Significantly to Market Growth
According to the American Society of Clinical Oncology (ASCO), in 2021, around 24,530 adults (13,840 men and 10,690 women) were diagnosed with primary cancerous tumors of the brain and spinal cord in the US. In a person's lifetime, the chances of having this form of tumor are fewer than 1%. Most primary central nervous system (CNS) malignancies are brain tumors, which account for 85% to 90% of all cases. Brain tumors can be fatal, severely impact the quality of life, and ultimately transform a patient's and their family's lives.
Similarly, Cancer Research UK estimated that around 12,288 new cases of brain, other CNS, and intracranial tumors are diagnosed in the UK each year, which makes it around 34 cases per day (2016–2018). Brain tumors, other central nervous systems, and intracranial tumors are the ninth most common malignancies in the UK, accounting for 3% of all new cancer cases (2016–2018). Also, it is the 7th most common cancer in females in the UK, with around 6,400 new cases during 2016–2018. Similarly, in males, brain, other CNS, and intracranial tumors are the 11th most common cancer, with about 5,800 new cases in the UK during 2016–2018. Incidence rates for brain tumors are highest in people aged 85 to 89 (2016-2018) in the UK.
According to the American Association of Neurological Surgeons, glioblastoma is the most common malignant brain and other CNS tumor, accounting for 47.7% of all cases; the incidence of glioblastoma is 3.21 per 100,000 people. According to Cancer Australia, around 1,879 new cases of brain cancer were diagnosed in Australia in 2020.
Early detection of tumors often provides more treatment options. Advanced imaging technology can pinpoint the location of brain tumors. Intraoperative MRI can also guide tissue biopsy and tumor resection during surgery. Magnetic resonance spectroscopy (MRS) is used to examine the chemical characteristics of tumors. Thus, the increase in the prevalence of brain cancer worldwide highly demands brain cancer diagnostic tools.
Diagnostic Type-Based Insights
Based on diagnostic type, the brain cancer diagnostics market is segmented into imaging test, lumbar puncture, biopsy, molecular testing, platform and services, cerebral arteriogram, neurological and hearing tests/neurocognitive assessments, electroencephalography (EEG), and others. Furthermore, the imaging test segment is sub-segmented into MRI, CT Scan, PET, and others. Similarly, the platform and services segment is sub-segmented into sample slide, autosampler unit, solutions and platform, and services. In 2022, the imaging test segment is likely to account for the largest share of the market. However, the platform and services segment is anticipated to register the highest CAGR in the brain cancer diagnostics market during the forecast period of 2022 to 2028.
Cancer Type-Based Insights
The global brain cancer diagnostics market , based on cancer type, is segmented into acoustic neuroma, astrocytomas, craniopharyngiomas, ganglioneuromas, glioblastoma multiforme, meningiomas, ependymomas, oligodendroglioma, low-grade tumors, and other brain cancer types. In 2022, the glioblastoma multiforme segment is likely to hold the largest share of the market. Moreover, the same segment is expected to witness growth in its demand at the fastest CAGR from 2022 to 2028, owing to the rise in the incidence of glioblastoma multiforme globally.
Tumor Size-Based Insights
The global brain cancer diagnostics market , based on tumor size, is segmented into 0.2 cm3 to 100 cm3, 101 cm3 to 200 cm3, and above 200 cm3. In 2022, the 0.2 cm3 to 100 cm3 segment is likely to hold the largest share of the market. Moreover, the 0.2 cm3 to 100 cm3 segment is expected to witness growth in its demand at the fastest CAGR from 2022 to 2028, owing to the rise in the detection and diagnosis of various medical conditions globally.
End User-Based Insights
Based on end user, the brain cancer diagnostics market is segmented into hospitals, specialty clinics, ambulatory surgical centers, diagnostic centers & research institutes, and others. In 2022, the hospitals segment is likely to hold the largest share of the market. Moreover, the specialty clinics segment is expected to witness growth in its demand at the fastest CAGR of 29.4% from 2022 to 2028, owing to the adoption of advanced technologies for brain cancer diagnosis by hospitals globally.
Product launches, mergers and acquisitions are highly adopted strategies by the global brain cancer diagnostics market players. A few of the recent key market developments are listed below:
In September 2021, BioReference Laboratories, Inc., an OPKO Health company, along with its specialty oncology division, GenPath, announced the launch of OnkoSight AdvancedTM, a next-generation sequencing (NGS) assay that enables revolutionary deoxyribonucleic acid (DNA) mutational profiling of tumor samples.
Geography-Based Insights
The global brain cancer diagnostics market , by geography, is broadly segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, the UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, and the Rest of APAC), the Middle East & Africa (Saudi Arabia, the UAE, South Africa, and the Rest of MEA), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).
Brain Cancer Diagnostics Market Report Scope
Company -Based Insights
THERMO FISHER SCIENTIFIC INC; Siemens Healthineers AG; GE Healthcare; MDxHealth; NantOmics; Biocept, Inc.; Koninklijke Philips N.V.; Canon Medical Systems; Hitachi, Ltd.; Neusoft Medical Systems; KITZ HEIDELBERG; GENPATH; NVIDIA CORPORATION; ONCORA MEDICAL; BIOMIND; SOPHIA AND ONCODNA; Clinspec Diagnostics; Raindance Technologies, Inc; ROCHE DIAGNOSTICS; and Illumina, Inc are among the leading companies operating in the brain cancer diagnostics market
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Diagnostic Type; Cancer Typ; End User ; and Tumor Size
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
Koninklijke Philips N.V. and GE Healthcare are the top two companies that hold huge market shares in the brain cancer diagnostics market.
Brain cancers are caused due to extracellular growth of the cells in the brain that causes tumors. The tumor includes primary brain tumors and secondary brain tumors. Primary brain tumors are formed in the brain and do not spread to other body parts, whereas secondary tumors, also known as metastases, are those cancers that began in another part of the body. Brain tumors are categorized into 40 major types that are further classified into two major groups, including benign, i.e., slow-growing and have less possibility to spread, and malignant, i.e., cancerous, and more likely to spread.
Key factors driving the growth of this market are the increase in brain cancer worldwide and the rise in cigarette smokers expected to drive the market during the forecast period.
In 2021, the glioblastoma multiforme segment accounted for the largest share of the market; it is further expected to continue its dominance over the forecast period. The major driving factor for the growth of the glioblastoma multiforme segment is the growing incidence of glioblastoma multiforme. Moreover, the increasing awareness about brain cancer diagnostics among the population is one of the significant factors in the growth of the glioblastoma multiforme segment.
In 2021, the imaging test held the largest share of the market by drug development type. It is expected to report a higher CAGR of 29.5% during 2021–2028.
The CAGR value of the brain cancer diagnostics market during the forecasted period of 2021–2028 is 28.5%.
The brain cancer diagnostics market majorly consists of players such as THERMO FISHER SCIENTIFIC INC, Siemens Healthineers AG, GE Healthcare, MDxHealth, NantOmics, Biocept, Inc., Koninklijke Philips N.V., Canon Medical Systems, Hitachi, Ltd., Neusoft Medical Systems, KITZ HEIDELBERG, GENPATH, NVIDIA CORPORATION, ONCORA MEDICAL, BIOMIND, SOPHIA AND ONCODNA, Clinspec Diagnostics, Raindance Technologies, Inc, ROCHE DIAGNOSTICS, Illumina, Inc.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Brain Cancer Diagnostics Market – By Diagnostic Type
1.3.2 Global Brain Cancer Diagnostics Market – By y Cancer Type
1.3.3 Global Brain Cancer Diagnostics Market – By End User
1.3.4 Global Brain Cancer Diagnostics Market – By Tumor Size
1.3.5 Global Brain Cancer Diagnostics Market – By Geography
2. Brain Cancer Diagnostics Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Brain Cancer Diagnostics Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East and Africa PEST Analysis
4.2.5 South and Central America PEST Analysis
4.3 Experts Opinion
5. Brain Cancer Diagnostics Market– Key Market Dynamics
5.1 Market Drivers
5.1.1 Increase in Brain Cancer Worldwide
5.1.2 Rise in Cigarette Smokers
5.2 Market Restraints
5.2.1 High Cost of Brain Tumor Diagnosis
5.3 Market Opportunities
5.3.1 Increasing R&D for Developing Advance Technology
5.4 Future Trends
5.4.1 Advancement in Brain Tumor Diagnosis
5.5 Impact Analysis
6. Brain Cancer Diagnostics Market– Global Analysis
6.1 Global Brain Cancer Diagnostics Market Revenue Forecast And Analysis
6.1.1 Global Brain Cancer Diagnostics Market Revenue Forecast And Analysis
6.1.2 Global Brain Cancer Diagnostics Market – Market Potential Analysis, By Region
6.2 Market Positioning Analysis Of Key Players In Brain Cancer Diagnostics Market
6.2.1 Company Analysis
6.2.2 Growth Strategy Analysis
6.2.3 Performance Of Key Players
6.2.3.1 Koninklijke Philips N.V.
6.2.3.2 GE Healthcare
7. Global Brain Cancer Diagnostic Market Revenue and Forecasts To 2028– by Diagnostic Type
7.1 Overview
7.2 Global Brain Cancer Diagnostic Market, By Diagnostic Type, 2021 & 2028 (%)
7.3 Imaging Test
7.3.1 Overview
7.3.2 Imaging Test: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)
7.3.2.1 MRI
7.3.2.1.1 Overview
7.3.2.1.2 MRI: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)
7.3.2.2 CT Scan
7.3.2.2.1 Overview
7.3.2.2.2 CT Scan: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)
7.3.2.3 PET
7.3.2.3.1 Overview
7.3.2.3.2 PET: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)
7.3.2.4 Others
7.3.2.4.1 Overview
7.3.2.4.2 Others: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)
7.4 Molecular Testing
7.4.1 Overview
7.4.2 Molecular Testing: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)
7.5 Lumbar Puncture
7.5.1 Overview
7.5.2 Lumbar Puncture: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)
7.6 Electroencephalography (EEG)
7.6.1 Overview
7.6.2 Electroencephalography (EEG): Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)
7.7 Platform and Services
7.7.1 Overview
7.7.2 Platform and Services: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)
7.7.2.1 Sample Slide
7.7.2.1.1 Overview
7.7.2.1.2 Sample Slide: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)
7.7.2.2 Autosampler Unit
7.7.2.2.1 Overview
7.7.2.2.2 Autosampler Unit: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)
7.7.2.3 Solutions and Platform
7.7.2.3.1 Overview
7.7.2.3.2 Solutions and Platform: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)
7.7.2.4 Services
7.7.2.4.1 Overview
7.7.2.4.2 Services: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)
7.8 Cerebral arteriogram
7.8.1 Overview
7.8.2 Cerebral arteriogram: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)
7.9 Neurological and hearing tests/Neurocognitive Assessments
7.9.1 Overview
7.9.2 Neurological and hearing tests/Neurocognitive Assessments: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)
7.10 Others
7.10.1 Overview
7.10.2 Others: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)
8. Brain Cancer Diagnostic Market Revenue and Forecasts To 2028 – Cancer Type
8.1 Overview
8.2 Global Brain Cancer Diagnostic Market Share by Cancer Type - 2021 & 2028 (%)
8.3 Glioblastoma Multiforme
8.3.1 Overview
8.3.2 Glioblastoma Multiforme: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)
8.4 Astrocytomas
8.4.1 Overview
8.4.2 Astrocytomas: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)
8.5 Ependymomas
8.5.1 Overview
8.5.2 Ependymomas: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)
8.6 Meningiomas
8.6.1 Overview
8.6.2 Meningiomas: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)
8.7 Low-Grade Tumors
8.7.1 Overview
8.7.2 Low-Grade Tumors: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)
8.8 Oligodendroglioma
8.8.1 Overview
8.8.2 Oligodendroglioma: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)
8.9 Acoustic Neuroma
8.9.1 Overview
8.9.2 Acoustic Neuroma: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)
8.10 Craniopharyngiomas
8.10.1 Overview
8.10.2 Craniopharyngiomas: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)
8.11 Ganglioneuromas
8.11.1 Overview
8.11.2 Ganglioneuromas: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)
8.12 Others
8.12.1 Overview
8.12.2 Others: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)
9. Brain Cancer Diagnostic Market Revenue and Forecasts To 2028 – Tumor Size
9.1 Overview
9.2 Global Brain Cancer Diagnostic Market Share by Tumor Size - 2021 & 2028 (%)
9.3 0.2 cm3 to 100 cm3
9.3.1 Overview
9.3.2 0.2 cm3 to 100 cm3: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)
9.4 cm3 to 200 cm3
9.4.1 Overview
9.4.2 cm3 to 200 cm3: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)
9.5 Above 200 cm3
9.5.1 Overview
9.5.2 Above 200 cm3: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)
10. Brain Cancer Diagnostic Market Revenue and Forecasts To 2028 – End User
10.1 Overview
10.2 Global Brain Cancer Diagnostic Market Share by End User- 2021 & 2028 (%)
10.3 Hospitals
10.3.1 Overview
10.3.2 Hospitals: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)
10.4 Specialty Clinics
10.4.1 Overview
10.4.2 Specialty Clinics: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)
10.5 Diagnostic Centers and Research Institutes
10.5.1 Overview
10.5.2 Diagnostic Centers and Research Institutes: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)
10.6 Ambulatory Surgical Centers
10.6.1 Overview
10.6.2 Ambulatory Surgical Centers: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)
10.7 Others
10.7.1 Overview
10.7.2 Others: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)
11. Brain Cancer Diagnostics Market Revenue and Forecast to 2028 – by Geography
11.1 North America: Brain Cancer Diagnostics Market
11.1.1 Overview
11.1.2 North America Brain Cancer Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.1.3 North America Brain Cancer Diagnostics Market, by Diagnostic Type– Revenue and Forecast to 2028 (USD Million)
11.1.3.1 North America Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)
11.1.3.2 North America Brain Cancer Diagnostics Market, by Platform and Services – Revenue and Forecast to 2028 (USD Million)
11.1.4 North America Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)
11.1.5 North America Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
11.1.6 North America Brain Cancer Diagnostics Market, by Tumor Size– Revenue and Forecast to 2028 (USD Million)
11.1.7 North America: Brain Cancer Diagnostics Market, by Country, 2022 & 2028 (%)
11.1.7.1 US: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.1.1 Overview
11.1.7.1.2 US: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.1.3 US Brain Cancer Diagnostics Market, by Diagnostic Type– Revenue and Forecast to 2028 (USD Million)
11.1.7.1.3.1 US Brain Cancer Diagnostics Market, by Imaging Test– Revenue and Forecast to 2028 (USD Million)
11.1.7.1.3.2 US Brain Cancer Diagnostics Market, by Platform and Services– Revenue and Forecast to 2028 (USD Million)
11.1.7.1.4 US Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)
11.1.7.1.5 US Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
11.1.7.1.6 US Brain Cancer Diagnostics Market, by Tumor Size – Revenue and Forecast to 2028 (USD Million)
11.1.7.2 Canada: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.2.1 Overview
11.1.7.2.2 Canada: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.2.3 Canada Brain Cancer Diagnostics Market, by Diagnostic Type– Revenue and Forecast to 2028 (USD Million)
11.1.7.2.3.1 Canada Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)
11.1.7.2.3.2 Canada Brain Cancer Diagnostics Market, by Platform and Services – Revenue and Forecast to 2028 (USD Million)
11.1.7.2.4 Canada Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)
11.1.7.2.5 Canada Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
11.1.7.2.6 Canada Brain Cancer Diagnostics Market, by Tumor Size– Revenue and Forecast to 2028 (USD Million)
11.1.7.3 Mexico: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.3.1 Overview
11.1.7.3.2 Mexico: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.3.3 Mexico Brain Cancer Diagnostics Market, by Diagnostic Type– Revenue and Forecast to 2028 (USD Million)
11.1.7.3.3.1 Mexico Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)
11.1.7.3.3.2 Mexico Brain Cancer Diagnostics Market, by Platform and Services – Revenue and Forecast to 2028 (USD Million)
11.1.7.3.4 Mexico Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)
11.1.7.3.5 Mexico Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
11.1.7.3.6 Mexico Brain Cancer Diagnostics Market, by Tumor Size– Revenue and Forecast to 2028 (USD Million)
11.2 Europe: Brain Cancer Diagnostics Market
11.2.1 Overview
11.2.2 Europe: Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)
11.2.3 Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)
11.2.3.1 Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Imaging Test (US$ Mn)
11.2.3.2 Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Platform and Services (US$ Mn)
11.2.4 Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)
11.2.5 Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)
11.2.6 Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Tumor Size (US$ Mn)
11.2.7 Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Country (%)
11.2.7.1 UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)
11.2.7.1.1 Overview
11.2.7.1.2 UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)
11.2.7.1.3 UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)
11.2.7.1.3.1 UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)
11.2.7.1.3.2 UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Platform and Services (US$ Mn)
11.2.7.1.4 UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)
11.2.7.1.5 UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)
11.2.7.1.6 UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Tumor Size (US$ Mn)
11.2.7.2 Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)
11.2.7.2.1 Overview
11.2.7.2.2 Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)
11.2.7.2.3 Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)
11.2.7.2.3.1 Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)
11.2.7.2.3.2 Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Platform and Services (US$ Mn)
11.2.7.2.4 Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)
11.2.7.2.5 Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)
11.2.7.2.6 Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Tumor Size (US$ Mn)
11.2.7.3 France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)
11.2.7.3.1 Overview
11.2.7.3.2 France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)
11.2.7.3.3 France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)
11.2.7.3.3.1 France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)
11.2.7.3.3.2 France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Platform and Services (US$ Mn)
11.2.7.3.4 France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)
11.2.7.3.5 France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)
11.2.7.3.6 France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Tumor Size (US$ Mn)
11.2.7.4 Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)
11.2.7.4.1 Overview
11.2.7.4.2 Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)
11.2.7.4.3 Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)
11.2.7.4.3.1 Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)
11.2.7.4.3.2 Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Platform and Services (US$ Mn)
11.2.7.4.4 Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)
11.2.7.4.5 Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)
11.2.7.5 Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Tumor Size (US$ Mn)
11.2.7.6 Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)
11.2.7.6.1 Overview
11.2.7.6.2 Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)
11.2.7.6.3 Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)
11.2.7.6.3.1 Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)
11.2.7.6.3.2 Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Platform and Services (US$ Mn)
11.2.7.6.4 Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)
11.2.7.6.5 Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)
11.2.7.7 Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)
11.2.7.7.1 Overview
11.2.7.7.2 Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)
11.2.7.7.3 Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)
11.2.7.7.3.1 Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)
11.2.7.7.3.2 Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Platform and Services (US$ Mn)
11.2.7.7.4 Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)
11.2.7.7.5 Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)
11.2.7.7.6 Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Tumor Size (US$ Mn)
11.3 Asia Pacific Brain Cancer Diagnostics Market Revenue and Forecast To 2028
11.3.1 Overview
11.3.2 Asia Pacific Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)
11.3.3 Asia Pacific: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Million)
11.3.3.1 Asia Pacific: Brain Cancer Diagnostic Market, by Imaging Test, 2019–2028 (US$ Million)
11.3.3.2 Asia Pacific: Brain Cancer Diagnostic Market, by Platform and Services, 2019–2028 (US$ Million)
11.3.4 Asia Pacific: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By Cancer Type (US$ Million)
11.3.5 Asia Pacific: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By Tumor Size (US$ Million)
11.3.6 Asia Pacific: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By End User (US$ Million)
11.3.7 Asia Pacific: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By Country (%)
11.3.7.1 Japan: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.1.1 Overview
11.3.7.1.2 Japan: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.1.3 Japan: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Million)
11.3.7.1.3.1 Japan: Brain Cancer Diagnostic Market, by Imaging Test, 2019–2028 (US$ Million)
11.3.7.1.3.2 Japan: Brain Cancer Diagnostic Market, by Platform and Services, 2019–2028 (US$ Million)
11.3.7.1.4 Japan: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By Cancer Type (US$ Million)
11.3.7.1.5 Japan: Brain Cancer Diagnostic Market, by Tumor Size– Revenue and Forecast to 2028 (US$ Million)
11.3.7.1.6 Japan: Brain Cancer Diagnostic Market, by End User– Revenue and Forecast to 2028 (US$ Million)
11.3.7.2 China: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.2.1 Overview
11.3.7.2.2 China: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.2.3 China: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Million)
11.3.7.2.3.1 China: Brain Cancer Diagnostic Market, by Imaging Test, 2019–2028 (US$ Million)
11.3.7.2.3.2 China: Brain Cancer Diagnostic Market, by Platform and Services, 2019–2028 (US$ Million)
11.3.7.2.4 China: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By Cancer Type (US$ Million)
11.3.7.2.5 China: Brain Cancer Diagnostic Market, by Tumor Size– Revenue and Forecast to 2028 (US$ Million)
11.3.7.2.6 China: Brain Cancer Diagnostic Market, by End User– Revenue and Forecast to 2028 (US$ Million)
11.3.7.3 India Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.3.1 Overview
11.3.7.3.2 India: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.3.3 India: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Million)
11.3.7.3.3.1 India: Brain Cancer Diagnostic Market, by Imaging Test, 2019–2028 (US$ Million)
11.3.7.3.3.2 India: Brain Cancer Diagnostic Market, by Platform and Services, 2019–2028 (US$ Million)
11.3.7.3.4 India: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By Cancer Type (US$ Million)
11.3.7.3.5 India: Brain Cancer Diagnostic Market, by Tumor Size– Revenue and Forecast to 2028 (US$ Million)
11.3.7.3.6 India: Brain Cancer Diagnostic Market, by End User – Revenue and Forecast to 2028 (US$ Million)
11.3.7.4 South Korea: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.4.1 Overview
11.3.7.4.2 South Korea: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.4.3 South Korea: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Million)
11.3.7.4.3.1 South Korea: Brain Cancer Diagnostic Market, by Imaging Test, 2019–2028 (US$ Million)
11.3.7.4.3.2 South Korea: Brain Cancer Diagnostic Market, by Platform and Services, 2019–2028 (US$ Million)
11.3.7.4.4 South Korea: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By Cancer Type (US$ Million)
11.3.7.4.5 South Korea: Brain Cancer Diagnostic Market, by Tumor Size– Revenue and Forecast to 2028 (US$ Million)
11.3.7.4.6 South Korea: Brain Cancer Diagnostic Market, by End User– Revenue and Forecast to 2028 (US$ Million)
11.3.7.5 Australia: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.5.1 Overview
11.3.7.5.2 Australia: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.5.3 Australia: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Million)
11.3.7.5.3.1 Australia: Brain Cancer Diagnostic Market, by Imaging Test, 2019–2028 (US$ Million)
11.3.7.5.3.2 Australia: Brain Cancer Diagnostic Market, by Platform and Services, 2019–2028 (US$ Million)
11.3.7.5.4 Australia: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By Cancer Type (US$ Million)
11.3.7.5.5 Australia: Brain Cancer Diagnostic Market, by Tumor Size– Revenue and Forecast to 2028 (US$ Million)
11.3.7.5.6 Australia: Brain Cancer Diagnostic Market, by End User– Revenue and Forecast to 2028 (US$ Million)
11.3.7.6 Rest of Asia Pacific: Brain Cancer Diagnostic Market – Revenue and Forecast to 2028 (US$ Million)
11.3.7.6.1 Overview
11.3.7.6.2 Rest of Asia Pacific: Brain Cancer Diagnostic Market – Revenue and Forecast to 2028 (US$ Million)
11.3.7.6.3 Rest of Asia Pacific: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Million)
11.3.7.6.3.1 Rest of Asia Pacific: Brain Cancer Diagnostic Market, by Imaging Test, 2019–2028 (US$ Million)
11.3.7.6.3.2 Rest of Asia Pacific: Brain Cancer Diagnostic Market, by Platform and Services, 2019–2028 (US$ Million)
11.3.7.6.4 Rest of Asia Pacific: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By Cancer Type (US$ Million)
11.3.7.6.5 Rest of Asia Pacific: Brain Cancer Diagnostic Market, by Tumor Size– Revenue and Forecast to 2028 (US$ Million)
11.3.7.6.6 Rest of Asia Pacific: Brain Cancer Diagnostic Market, by End User– Revenue and Forecast to 2028 (US$ Million)
11.4 Middle East & Africa Brain Cancer Diagnostics Market Revenue and Forecast To 2028
11.4.1 Overview
11.4.2 Middle East and Africa: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)
11.4.3 Middle East and Africa: Brain Cancer Diagnostics, By Diagnostic Type 2019–2028 (US$ ‘Million)
11.4.3.1 Middle East and Africa: Brain Cancer Diagnostics, By Imaging Test 2019–2028 (US$ ‘Million)
11.4.3.2 Middle East and Africa: Brain Cancer Diagnostics, By Platform and Services 2019–2028 (US$ ‘Million)
11.4.4 Middle East and Africa: Brain Cancer Diagnostics Market, By Cancer Type, 2019–2028 (US$ ‘Million)
11.4.5 Middle East and Africa: Brain Cancer Diagnostics Market, by End User, 2019–2028 (US$ Million)
11.4.6 Middle East and Africa: Brain Cancer Diagnostics Market, by Tumor Size, 2019–2028 (US$ Million)
11.4.7 Middle East and Africa: Brain Cancer Diagnostics Market, by Country, 2022 & 2028 (%)
11.4.7.1 UAE: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)
11.4.7.1.1 UAE: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)
11.4.7.1.2 UAE: Brain Cancer Diagnostics, By Diagnostic Type 2019–2028 (US$ ‘Million)
11.4.7.1.2.1 UAE: Brain Cancer Diagnostics, By Platform and Services 2019–2028 (US$ ‘Million)
11.4.7.1.2.2 UAE: Brain Cancer Diagnostics, by Imaging Test 2019–2028 (US$ ‘Million)
11.4.7.1.3 UAE: Brain Cancer Diagnostics Market, By Cancer Type, 2019–2028 (US$ ‘Million)
11.4.7.1.4 UAE: Brain Cancer Diagnostics Market, by End User, 2019–2028 (US$ ‘Million)
11.4.7.1.5 UAE: Brain Cancer Diagnostics Market, by Tumor Size, 2019–2028 (US$ ‘Million)
11.4.7.2 Saudi Arabia: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)
11.4.7.2.1 Saudi Arabia: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)
11.4.7.2.2 Saudi Arabia: Brain Cancer Diagnostics Market, By Diagnostic Type, 2019–2028 (US$ ‘Million)
11.4.7.2.2.1 Saudi Arabia: Brain Cancer Diagnostics Market, By Imaging Test, 2019–2028 (US$ ‘Million)
11.4.7.2.2.2 Saudi Arabia: Brain Cancer Diagnostics Market, By Platform and Services, 2019–2028 (US$ ‘Million)
11.4.7.2.3 Saudi Arabia: Brain Cancer Diagnostics Market, By Cancer Type, 2019–2028 (US$ ‘Million)
11.4.7.2.4 Saudi Arabia: Brain Cancer Diagnostics Market, by End User, 2019–2028 (US$ ‘Million)
11.4.7.2.5 Saudi Arabia: Brain Cancer Diagnostics Market, by Tumor Size, 2019–2028 (US$ ‘Million)
11.4.7.3 South Africa: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)
11.4.7.3.1 South Africa: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)
11.4.7.3.2 South Africa: Brain Cancer Diagnostics Market, By Diagnostic Type, 2019–2028 (US$ ‘Million)
11.4.7.3.2.1 South Africa: Brain Cancer Diagnostics Market, by Imaging Test, 2019–2028 (US$ ‘Million)
11.4.7.3.2.2 South Africa: Brain Cancer Diagnostics Market, By Platform and Services, 2019–2028 (US$ ‘Million)
11.4.7.3.3 South Africa: Brain Cancer Diagnostics Market, By Cancer Type, 2019–2028 (US$ ‘Million)
11.4.7.3.4 South Africa: Brain Cancer Diagnostics Market, by End User, 2019–2028 (US$ ‘Million)
11.4.7.3.5 South Africa: Brain Cancer Diagnostics Market, by Tumor Size, 2019–2028 (US$ ‘Million)
11.4.7.4 Rest of Middle East and Africa: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)
11.4.7.4.1 Rest of Middle East and Africa: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)
11.4.7.4.2 Rest of Middle East and Africa: Brain Cancer Diagnostics, By Diagnostic Type, 2019–2028 (US$ ‘Million)
11.4.7.4.2.1 Rest of Middle East and Africa: Brain Cancer Diagnostics, By Imaging Test, 2019–2028 (US$ ‘Million)
11.4.7.4.2.2 Rest of Middle East and Africa: Brain Cancer Diagnostics, By Platform and Services, 2019–2028 (US$ ‘Million)
11.4.7.4.3 Rest of Middle East and Africa: Brain Cancer Diagnostics Market, By Cancer Type, 2019–2028 (US$ ‘Million)
11.4.7.4.4 Rest of Middle East and Africa: Brain Cancer Diagnostics Market, by End User, 2019–2028 (US$ ‘Million)
11.4.7.4.5 Rest of Middle East and Africa: Brain Cancer Diagnostics Market, by Tumor Size, 2019–2028 (US$ ‘Million)
11.5 South and Central America Brain Cancer Diagnostics Market Revenue and Forecast To 2028
11.5.1 Overview
11.5.2 South and Central America: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (USD Million)
11.5.3 South and Central America Brain Cancer Diagnostics Market, by Diagnostics Type – Revenue and Forecast to 2028 (USD Million)
11.5.3.1 South and Central America Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)
11.5.3.2 South and Central America Brain Cancer Diagnostics Market, by Platform and Services – Revenue and Forecast to 2028 (USD Million)
11.5.4 South and Central America Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)
11.5.5 South and Central America Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
11.5.6 South and Central America Brain Cancer Diagnostics Market, by Tumor Size– Revenue and Forecast to 2028 (USD Million)
11.5.7 South and Central America: Brain Cancer Diagnostics Market, by Country, 2021 & 2028 (%)
11.5.7.1 Brazil: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (USD Million)
11.5.7.1.1 Overview
11.5.7.1.2 Brazil: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (USD Million)
11.5.7.1.3 Brazil Brain Cancer Diagnostics Market, by Diagnostics Type– Revenue and Forecast to 2028 (USD Million)
11.5.7.1.3.1 Brazil Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)
11.5.7.1.3.2 Brazil Brain Cancer Diagnostics Market, by Platform and Services – Revenue and Forecast to 2028 (USD Million)
11.5.7.1.4 Brazil Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)
11.5.7.1.5 Brazil Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
11.5.7.1.6 Brazil Brain Cancer Diagnostics Market, by Tumor Size – Revenue and Forecast to 2028 (USD Million)
11.5.7.2 Argentina: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (USD Million)
11.5.7.2.1 Overview
11.5.7.2.2 Argentina: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (USD Million)
11.5.7.2.3 Argentina Brain Cancer Diagnostics Market, by Diagnostics Type– Revenue and Forecast to 2028 (USD Million)
11.5.7.2.3.1 Argentina Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)
11.5.7.2.3.2 Argentina Brain Cancer Diagnostics Market, by Platform and Services – Revenue and Forecast to 2028 (USD Million)
11.5.7.2.4 Argentina Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)
11.5.7.2.5 Argentina Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
11.5.7.2.6 Argentina Brain Cancer Diagnostics Market, by Tumor Size – Revenue and Forecast to 2028 (USD Million)
11.5.7.3 Rest of South and Central America: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (USD Million)
11.5.7.3.1 Overview
11.5.7.3.2 Rest of South and Central America: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (USD Million)
11.5.7.3.3 Rest of South and Central America Brain Cancer Diagnostics Market, by Diagnostics Type– Revenue and Forecast to 2028 (USD Million)
11.5.7.3.3.1 Rest of South and Central America Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)
11.5.7.3.3.2 Rest of South and Central America Brain Cancer Diagnostics Market, by Platform and Services – Revenue and Forecast to 2028 (USD Million)
11.5.7.3.4 Rest of South and Central America Brain Cancer Diagnostics Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)
11.5.7.3.5 Rest of South and Central America Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
11.5.7.3.6 Rest of South and Central America Brain Cancer Diagnostics Market, by Tumor Size– Revenue and Forecast to 2028 (USD Million)
12. Impact of COVID-19 Pandemic on Global Brain Cancer Diagnostics Market
12.1 North America: Impact Assessment of COVID-19 Pandemic
12.2 Europe: Impact Assessment of COVID-19 Pandemic
12.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
12.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
12.5 South and Central America: Impact Assessment of COVID-19 Pandemic
13. Brain Cancer Diagnostics Market–Industry Landscape
13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market, (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview
14. Company Profiles
14.1 THERMO FISHER SCIENTIFIC INC.
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Siemens Healthineers AG
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 GE Healthcare
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 MDxHealth
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 NantOmics
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Biocept, Inc.
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Koninklijke Philips N.V.
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Canon Medical Systems
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Hitachi, Ltd.
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Neusoft Medical Systems
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
14.11 KITZ HEIDELBERG
14.11.1 Key Facts
14.11.2 Business Description
14.11.3 Products and Services
14.11.4 Financial Overview
14.11.5 SWOT Analysis
14.11.6 Key Developments
14.12 GENPATH
14.12.1 Key Facts
14.12.2 Business Description
14.12.3 Products and Services
14.12.4 Financial Overview
14.12.5 SWOT Analysis
14.12.6 Key Developments
14.13 NVIDIA CORPORATION
14.13.1 Key Facts
14.13.2 Business Description
14.13.3 Products and Services
14.13.4 Financial Overview
14.13.5 SWOT Analysis
14.13.6 Key Developments
14.14 ONCORA MEDICAL
14.14.1 Key Facts
14.14.2 Business Description
14.14.3 Products and Services
14.14.4 Financial Overview
14.14.5 SWOT Analysis
14.14.6 Key Developments
14.15 BIOMIND
14.15.1 Key Facts
14.15.2 Business Description
14.15.3 Products and Services
14.15.4 Financial Overview
14.15.5 SWOT Analysis
14.15.6 Key Developments
14.16 SOPHIA AND ONCODNA
14.16.1 Key Facts
14.16.2 Business Description
14.16.3 Products and Services
14.16.4 Financial Overview
14.16.5 SWOT Analysis
14.16.6 Key Developments
14.17 Clinspec Diagnostics
14.17.1 Key Facts
14.17.2 Business Description
14.17.3 Products and Services
14.17.4 Financial Overview
14.17.5 SWOT Analysis
14.17.6 Key Developments
14.18 Raindance Technologies, Inc
14.18.1 Key Facts
14.18.2 Business Description
14.18.3 Products and Services
14.18.4 Financial Overview
14.18.5 SWOT Analysis
14.18.6 Key Developments
14.19 ROCHE DIAGNOSTICS
14.19.1 Key Facts
14.19.2 Business Description
14.19.3 Products and Services
14.19.4 Financial Overview
14.19.5 SWOT Analysis
14.19.6 Key Developments
14.20 Illumina, Inc.
14.20.1 Key Facts
14.20.2 Business Description
14.20.3 Products and Services
14.20.4 Financial Overview
14.20.5 SWOT Analysis
14.20.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Brain Cancer Diagnostics Market, by Diagnostic Type – Revenue and Forecast to 2028 (USD Million)
Table 2. North America Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)
Table 3. North America Brain Cancer Diagnostics Market, by Platform and Services – Revenue and Forecast to 2028 (USD Million)
Table 4. North America Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)
Table 5. North America Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 6. North America Brain Cancer Diagnostics Market, by Tumor Size– Revenue and Forecast to 2028 (USD Million)
Table 7. US Brain Cancer Diagnostics Market, by Diagnostic Type – Revenue and Forecast to 2028 (USD Million)
Table 8. US Brain Cancer Diagnostics Market, by Imaging Test– Revenue and Forecast to 2028 (USD Million)
Table 9. US Brain Cancer Diagnostics Market, by Platform and Services– Revenue and Forecast to 2028 (USD Million)
Table 10. US Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)
Table 11. US Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 12. US Brain Cancer Diagnostics Market, by Tumor Size– Revenue and Forecast to 2028 (USD Million)
Table 13. Canada Brain Cancer Diagnostics Market, by Diagnostic Type-Revenue and Forecast to 2028 (USD Million)
Table 14. Canada Brain Cancer Diagnostics Market, by Imaging Test -Revenue and Forecast to 2028 (USD Million)
Table 15. Canada Brain Cancer Diagnostics Market, by Platform and Services -Revenue and Forecast to 2028 (USD Million)
Table 16. Canada Brain Cancer Diagnostics Market, by Cancer Type -Revenue and Forecast to 2028 (USD Million)
Table 17. Canada Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 18. Canada Brain Cancer Diagnostics Market, by Tumor Size– Revenue and Forecast to 2028 (USD Million)
Table 19. Mexico Brain Cancer Diagnostics Market, by Diagnostic Type -Revenue and Forecast to 2028 (USD Million)
Table 20. Mexico Brain Cancer Diagnostics Market, by Imaging Test -Revenue and Forecast to 2028 (USD Million)
Table 21. Mexico Brain Cancer Diagnostics Market, by Platform and Services -Revenue and Forecast to 2028 (USD Million)
Table 22. Mexico Brain Cancer Diagnostics Market, by Cancer Type -Revenue and Forecast to 2028 (USD Million)
Table 23. Mexico Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 24. Mexico Brain Cancer Diagnostics Market, by Tumor Size– Revenue and Forecast to 2028 (USD Million)
Table 25. Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)
Table 26. Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)
Table 27. Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Platform and Services (US$ Mn).
Table 28. Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)
Table 29. Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)
Table 30. Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Tumor Size (US$ Mn)
Table 31. UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type US$ Mn)
Table 32. UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test US$ Mn)
Table 33. UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Platform and Services US$ Mn)
Table 34. UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type US$ Mn)
Table 35. UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User US$ Mn)
Table 36. UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Tumor Size US$ Mn)
Table 37. Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)
Table 38. Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)
Table 39. Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Platform and Services (US$ Mn)
Table 40. Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type US$ Mn)
Table 41. Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User US$ Mn)
Table 42. Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Tumor Size US$ Mn)
Table 43. France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)
Table 44. France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)
Table 45. France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Platform and Services (US$ Mn)
Table 46. France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)
Table 47. France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)
Table 48. France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Tumor Size (US$ Mn)
Table 49. Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)
Table 50. Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)
Table 51. Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Platform and Services (US$ Mn)
Table 52. Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)
Table 53. Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)
Table 54. Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Tumor Size (US$ Mn)
Table 55. Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)
Table 56. Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)
Table 57. Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Platform and Services (US$ Mn)
Table 58. Spain Brain Cancer Diagnostics Market Revenue and Forecast to 2028, by Cancer Type (USD Million)
Table 59. Spain Brain Cancer Diagnostics Market Revenue and Forecast to 2028, by End User (USD Million)
Table 60. Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)
Table 61. Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)
Table 62. Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Platform and Services (US$ Mn)
Table 63. Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)
Table 64. Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)
Table 65. Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Tumor Size (US$ Mn)
Table 66. Asia Pacific: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Million).
Table 67. Asia Pacific: Brain Cancer Diagnostic Market, by Imaging Test – Revenue and Forecast to 2028 (US$ Million)
Table 68. Asia Pacific: Brain Cancer Diagnostic Market, by Platform and Services – Revenue and Forecast to 2028 (US$ Million)
Table 69. Asia Pacific: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By Cancer Type (US$ Million)
Table 70. Asia Pacific: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By Tumor Size (US$ Million)
Table 71. Asia Pacific: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 72. Japan: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Million)
Table 73. Japan: Brain Cancer Diagnostic Market, by Imaging Test– Revenue and Forecast to 2028 (US$ Million)
Table 74. Japan: Brain Cancer Diagnostic Market, by Platform and Services– Revenue and Forecast to 2028 (US$ Million)
Table 75. Japan: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By Cancer Type (US$ Million)
Table 76. Japan: Brain Cancer Diagnostic Market, by Tumor Size– Revenue and Forecast to 2028 (US$ Million)
Table 77. Japan: Brain Cancer Diagnostic Market, by End User– Revenue and Forecast to 2028 (US$ Million)
Table 78. China: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Million)
Table 79. China: Brain Cancer Diagnostic Market, by Imaging Test– Revenue and Forecast to 2028 (US$ Million)
Table 80. China: Brain Cancer Diagnostic Market, by Platform and Services– Revenue and Forecast to 2028 (US$ Million)
Table 81. China: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By Cancer Type (US$ Million)
Table 82. China: Brain Cancer Diagnostic Market, by Tumor Size– Revenue and Forecast to 2028 (US$ Million)
Table 83. China: Brain Cancer Diagnostic Market, by End User– Revenue and Forecast to 2028 (US$ Million)
Table 84. India: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Million)
Table 85. India: Brain Cancer Diagnostic Market, by Imaging Test– Revenue and Forecast to 2028 (US$ Million)
Table 86. India: Brain Cancer Diagnostic Market, by Platform and Services– Revenue and Forecast to 2028 (US$ Million)
Table 87. India: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By Cancer Type (US$ Million)
Table 88. India: Brain Cancer Diagnostic Market, by Tumor Size– Revenue and Forecast to 2028 (US$ Million)
Table 89. India: Brain Cancer Diagnostic Market, by End User– Revenue and Forecast to 2028 (US$ Million)
Table 90. South Korea: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Million)
Table 91. South Korea: Brain Cancer Diagnostic Market, by Imaging Test– Revenue and Forecast to 2028 (US$ Million)
Table 92. South Korea: Brain Cancer Diagnostic Market, by Platform and Services– Revenue and Forecast to 2028 (US$ Million)
Table 93. South Korea: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By Cancer Type (US$ Million)
Table 94. South Korea: Brain Cancer Diagnostic Market, by Tumor Size– Revenue and Forecast to 2028 (US$ Million)
Table 95. South Korea: Brain Cancer Diagnostic Market, by End User– Revenue and Forecast to 2028 (US$ Million)
Table 96. Australia: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Million)
Table 97. Australia: Brain Cancer Diagnostic Market, by Imaging Test– Revenue and Forecast to 2028 (US$ Million)
Table 98. Australia: Brain Cancer Diagnostic Market, by Platform and Services– Revenue and Forecast to 2028 (US$ Million)
Table 99. Australia: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By Cancer Type (US$ Million)
Table 100. Australia: Brain Cancer Diagnostic Market, by Tumor Size– Revenue and Forecast to 2028 (US$ Million)
Table 101. Australia: Brain Cancer Diagnostic Market, by End User– Revenue and Forecast to 2028 (US$ Million)
Table 102. Rest of Asia Pacific: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Million)
Table 103. Rest of Asia Pacific: Brain Cancer Diagnostic Market, by Imaging Test– Revenue and Forecast to 2028 (US$ Million)
Table 104. Rest of Asia Pacific: Brain Cancer Diagnostic Market, by Platform and Services– Revenue and Forecast to 2028 (US$ Million)
Table 105. Rest of Asia Pacific: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By Cancer Type (US$ Million)
Table 106. Rest of Asia Pacific: Brain Cancer Diagnostic Market, by Tumor Size– Revenue and Forecast to 2028 (US$ Million)
Table 107. Rest of Asia Pacific: Brain Cancer Diagnostic Market, by End User– Revenue and Forecast to 2028 (US$ Million)
Table 108. Middle East and Africa: Brain Cancer Diagnostics Market, By Diagnostic Type– Revenue and Forecast to 2028 (US$ ‘Million)
Table 109. Middle East and Africa: Brain Cancer Diagnostics Market, By Imaging Test – Revenue and Forecast to 2028 (US$ ‘Million)
Table 110. Middle East and Africa: Brain Cancer Diagnostics Market, By Platform and Services – Revenue and Forecast to 2028 (US$ ‘Million)
Table 111. Middle East and Africa: Brain Cancer Diagnostics Market, By Cancer Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 112. Middle East and Africa: ? Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 113. Middle East and Africa: ? Brain Cancer Diagnostics Market, by Tumor Size– Revenue and Forecast to 2028 (US$ Million)
Table 114. UAE: Brain Cancer Diagnostics Market, By Diagnostic Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 115. UAE: Brain Cancer Diagnostics Market, By Platform and Services – Revenue and Forecast to 2028 (US$ ‘Million)
Table 116. UAE: Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (US$ ‘Million)
Table 117. UAE: ? Brain Cancer Diagnostics Market, By Cancer Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 118. UAE: Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ ‘Million)
Table 119. UAE: Brain Cancer Diagnostics Market, by Tumor Size– Revenue and Forecast to 2028 (US$ ‘Million)
Table 120. Saudi Arabia: Brain Cancer Diagnostics Market, By Diagnostic Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 121. Saudi Arabia: Brain Cancer Diagnostics Market, By Imaging Test – Revenue and Forecast to 2028 (US$ ‘Million)
Table 122. Saudi Arabia: Brain Cancer Diagnostics Market, By Platform and Services – Revenue and Forecast to 2028 (US$ ‘Million)
Table 123. Saudi Arabia: ? Brain Cancer Diagnostics Market, By Cancer Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 124. Saudi Arabia: Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ ‘Million)
Table 125. Saudi Arabia: Brain Cancer Diagnostics Market, by Tumor Size– Revenue and Forecast to 2028 (US$ ‘Million)
Table 126. South Africa: Brain Cancer Diagnostics Market, By Diagnostic Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 127. South Africa: Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (US$ ‘Million)
Table 128. South Africa: Brain Cancer Diagnostics Market, By Platform and Services – Revenue and Forecast to 2028 (US$ ‘Million)
Table 129. South Africa: Brain Cancer Diagnostics Market, By Cancer Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 130. South Africa: Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ ‘Million)
Table 131. South Africa: Brain Cancer Diagnostics Market, by Tumor Size– Revenue and Forecast to 2028 (US$ ‘Million)
Table 132. Rest of Middle East and Africa: Brain Cancer Diagnostics Market, By Diagnostic Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 133. Rest of Middle East and Africa: Brain Cancer Diagnostics Market, By Imaging Test – Revenue and Forecast to 2028 (US$ ‘Million)
Table 134. Rest of Middle East and Africa: Brain Cancer Diagnostics Market, By Platform and Services – Revenue and Forecast to 2028 (US$ ‘Million)
Table 135. Rest of Middle East and Africa: Brain Cancer Diagnostics Market, By Cancer Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 136. Rest of Middle East and Africa: Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (US$ ‘Million)
Table 137. Rest of Middle East and Africa: Brain Cancer Diagnostics Market, by Tumor Size– Revenue and Forecast to 2028 (US$ ‘Million)
Table 138. South and Central America Brain Cancer Diagnostics Market, by Diagnostics Type – Revenue and Forecast to 2028 (USD Million)
Table 139. South and Central America Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)
Table 140. South and Central America Brain Cancer Diagnostics Market, by Platform and Services – Revenue and Forecast to 2028 (USD Million)
Table 141. South and Central America Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)
Table 142. South and Central America Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 143. South and Central America Brain Cancer Diagnostics Market, by Tumor Size – Revenue and Forecast to 2028 (USD Million)
Table 144. Brazil Brain Cancer Diagnostics Market, by Diagnostics Type – Revenue and Forecast to 2028 (USD Million)
Table 145. Brazil Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)
Table 146. Brazil Brain Cancer Diagnostics Market, by Platform and Services – Revenue and Forecast to 2028 (USD Million)
Table 147. Brazil Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)
Table 148. Brazil Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 149. Brazil Brain Cancer Diagnostics Market, by Tumor Size – Revenue and Forecast to 2028 (USD Million)
Table 150. Argentina Brain Cancer Diagnostics Market, by Diagnostics Type – Revenue and Forecast to 2028 (USD Million)
Table 151. Argentina Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)
Table 152. Argentina Brain Cancer Diagnostics Market, by Platform and Services – Revenue and Forecast to 2028 (USD Million)
Table 153. Argentina Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)
Table 154. Argentina Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 155. Argentina Brain Cancer Diagnostics Market, by Tumor Size – Revenue and Forecast to 2028 (USD Million)
Table 156. Rest of South and Central America Brain Cancer Diagnostics Market, by Diagnostics Type – Revenue and Forecast to 2028 (USD Million)
Table 157. Rest of South and Central America Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)
Table 158. Rest of South and Central America Brain Cancer Diagnostics Market, by Platform and Services – Revenue and Forecast to 2028 (USD Million)
Table 159. Rest of South and Central America Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)
Table 160. Rest of South and Central America Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 161. Rest of South and Central America Brain Cancer Diagnostics Market, by Tumor Size – Revenue and Forecast to 2028 (USD Million)
Table 162. Organic Developments Done By Companies
Table 163. Inorganic Developments Done By Companies
Table 164. Glossary of Terms, Brain Cancer Diagnostics Market
LIST OF FIGURES
Figure 1. Brain Cancer Diagnostics Market Segmentation
Figure 2. Brain Cancer Diagnostics Market – By Geography
Figure 3. Brain Cancer Diagnostics Market Overview
Figure 4. Amniotic Membranes Held Largest Share by Diagnostics Type of Brain Cancer Diagnostics Market
Figure 5. Asia Pacific to Show Significant Growth During Forecast Period
Figure 6. Brain Cancer Diagnostics Market, by Geography (US$ Million)
Figure 7. Global Brain Cancer Diagnostics Market – Leading Country Markets (US$ Million)
Figure 8. Global Brain Cancer Diagnostics Market, Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. Middle East and Africa: PEST Analysis
Figure 13. South and Central America: PEST Analysis
Figure 14. Experts Opinion
Figure 15. Global Brain Cancer Diagnostics Market– Revenue Forecast And Analysis – 2020- 2028
Figure 16. Global Brain Cancer Diagnostics Market– Revenue Forecast And Analysis – 2021 - 2028
Figure 17. Global Brain Cancer Diagnostics Market – Market Potential Analysis, By Region
Figure 18. Market Positioning Analysis Of Key Players In Global Brain Cancer Diagnostics Market
Figure 19. Global Brain Cancer Diagnostics Market – Comparative Company Analysis
Figure 20. Global Brain Cancer Diagnostics Market – Growth Strategy Analysis
Figure 21. Global Brain Cancer Diagnostic Market, by Diagnostic Type, 2021 & 2028 (%)
Figure 22. Imaging Test: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)
Figure 23. MRI: Brain Cancer Diagnostic Market Revenue and Forecasts To 2028 (US$ Million)
Figure 24. CT Scan: Brain Cancer Diagnostic Market Revenue and Forecasts To 2028 (US$ Million)
Figure 25. PET: Brain Cancer Diagnostic Market Revenue and Forecasts To 2028 (US$ Million)
Figure 26. Others: Brain Cancer Diagnostic Market Revenue and Forecasts To 2028 (US$ Million)
Figure 27. Molecular Testing: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)
Figure 28. Lumbar Puncture: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)
Figure 29. Electroencephalography (EEG): Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)
Figure 30. Platform and Services: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)
Figure 31. Sample Slide: Brain Cancer Diagnostic Market Revenue and Forecasts To 2028 (US$ Million)
Figure 32. Autosampler Unit: Brain Cancer Diagnostic Market Revenue and Forecasts To 2028 (US$ Million)
Figure 33. Solutions and Platform: Brain Cancer Diagnostic Market Revenue and Forecasts To 2028 (US$ Million)
Figure 34. Services: Brain Cancer Diagnostic Market Revenue and Forecasts To 2028 (US$ Million)
Figure 35. Cerebral arteriogram: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)
Figure 36. Neurological and hearing tests/Neurocognitive Assessments: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)
Figure 37. Others: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)
Figure 38. Global Brain Cancer Diagnostic Market Share by Cancer Type - 2021 & 2028 (%)
Figure 39. Glioblastoma Multiforme: Brain Cancer Diagnostic Market Revenue and Forecasts To 2028 (US$ Million)
Figure 40. Astrocytomas: Brain Cancer Diagnostic Market Revenue and Forecasts To 2028 (US$ Million)
Figure 41. Ependymomas: Brain Cancer Diagnostic Market Revenue and Forecasts To 2028 (US$ Million)
Figure 42. Meningiomas: Brain Cancer Diagnostic Market Revenue and Forecasts To 2028 (US$ Million)
Figure 43. Low-Grade Tumors: Brain Cancer Diagnostic Market Revenue and Forecasts To 2028 (US$ Million)
Figure 44. Oligodendroglioma: Brain Cancer Diagnostic Market Revenue and Forecasts To 2028 (US$ Million)
Figure 45. Acoustic Neuroma: Brain Cancer Diagnostic Market Revenue and Forecasts To 2028 (US$ Million)
Figure 46. Craniopharyngiomas: Brain Cancer Diagnostic Market Revenue and Forecasts To 2028 (US$ Million)
Figure 47. Ganglioneuromas: Brain Cancer Diagnostic Market Revenue and Forecasts To 2028 (US$ Million)
Figure 48. Others: Brain Cancer Diagnostic Market Revenue and Forecasts To 2028 (US$ Million)
Figure 49. Global Brain Cancer Diagnostic Market Share by Tumor Size - 2021 & 2028 (%)
Figure 50. 0.2 cm3 to 100 cm3: Brain Cancer Diagnostic Market Revenue and Forecasts To 2028 (US$ Million)
Figure 51. cm3 to 200 cm3: Brain Cancer Diagnostic Market Revenue and Forecasts To 2028 (US$ Million)
Figure 52. Above 200 cm3: Brain Cancer Diagnostic Market Revenue and Forecasts To 2028 (US$ Million)
Figure 53. Global Brain Cancer Diagnostic Market Share by End User- 2021 & 2028 (%)
Figure 54. Hospitals: Brain Cancer Diagnostic Market Revenue and Forecasts To 2028 (US$ Million)
Figure 55. Specialty Clinics: Brain Cancer Diagnostic Market Revenue and Forecasts To 2028 (US$ Million)
Figure 56. Diagnostic Centers and Research Institutes: Brain Cancer Diagnostic Market Revenue and Forecasts To 2028 (US$ Million)
Figure 57. Ambulatory Surgical Centers: Brain Cancer Diagnostic Market Revenue and Forecasts To 2028 (US$ Million)
Figure 58. Others: Brain Cancer Diagnostic Market Revenue and Forecasts To 2028 (US$ Million)
Figure 59. North America: Brain Cancer Diagnostics Market, by Key Country – Revenue (2022) (USD Million)
Figure 60. North America Brain Cancer Diagnostics Market Revenue and Forecast to 2028 (USD Million)
Figure 61. North America: Brain Cancer Diagnostics Market, by Country, 2022 & 2028 (%)
Figure 62. US: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 63. Canada: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 64. Mexico: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 65. Europe: Brain Cancer Diagnostics Market Revenue Overview, by Country, 2022(US$ MN)
Figure 66. Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 67. Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Country (%)
Figure 68. UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 69. Germany Brain Cancer Diagnostics Products Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 70. France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 71. Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 72. Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 73. Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 74. Asia Pacific Brain Cancer Diagnostic Market Overview, by Country (2021)
Figure 75. Asia Pacific: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)
Figure 76. Asia Pacific: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By Country (%)
Figure 77. Japan: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)
Figure 78. China: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)
Figure 79. India: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)
Figure 80. South Korea: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)
Figure 81. Australia: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)
Figure 82. Rest of Asia Pacific: Brain Cancer Diagnostic Market – Revenue and Forecast to 2028 (US$ Million)
Figure 83. Middle East and Africa: Brain Cancer Diagnostics Market, by Key Country – Revenue (2022) (US$ ‘Million)
Figure 84. Middle East and Africa: Brain Cancer Diagnostics Market Revenue and Forecast to 2028 (US$ ‘Million)
Figure 85. Middle East and Africa: Brain Cancer Diagnostics Market, by Country, 2022 & 2028 (%)
Figure 86. UAE: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 87. Saudi Arabia: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 88. South Africa: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 89. Rest of Middle East and Africa: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 90. South and Central America: Brain Cancer Diagnostics Market, by Key Country – Revenue (2021) (USD Million)
Figure 91. South and Central America Brain Cancer Diagnostics Market Revenue and Forecast to 2028 (USD Million)
Figure 92. South and Central America: Brain Cancer Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 93. Brazil: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (USD Million)
Figure 94. Argentina: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (USD Million)
Figure 95. Rest of South and Central America: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (USD Million)
Figure 96. Impact of COVID-19 Pandemic in North American Country Markets
Figure 97. Impact of COVID-19 Pandemic on Brain Cancer Diagnostics Market in Asia Pacific Countries
Figure 98. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 99. Impact Of COVID-19 Pandemic in Middle East & Africa Country Markets
Figure 100. Growth Strategies Done by the Companies in the Market, (%)
The List of Companies - Brain Cancer Diagnostics Market
- THERMO FISHER SCIENTIFIC INC
- Siemens Healthineers AG
- GE Healthcare
- MDxHealth
- NantOmics
- Biocept, Inc.
- Koninklijke Philips N.V.
- Canon Medical Systems
- Hitachi, Ltd
- Neusoft Medical Systems
- KITZ HEIDELBERG
- GENPATH
- NVIDIA CORPORATION
- ONCORA MEDICAL
- BIOMIND
- SOPHIA AND ONCODNA
- Clinspec Diagnostics
- Raindance Technologies, Inc
- ROCHE DIAGNOSTICS
- Illumina, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Brain Cancer Diagnostics Market
Jun 2022
Laser-Assisted ENT Surgeries Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Laser Type (C02 Laser, Nd:YAG Laser, Diode Laser, Blue Laser, KTP Laser, Argon Laser, and Other Laser Types), Surgery Type [Laser Laryngeal Surgery, Laser Endoscopic Sinus Surgery (LESS), Laser-Assisted Uvulopalatoplasty (LAUP), Laser-Assisted Stapedotomy, Laser-Assisted Tonsillectomy and Adenoidectomy, Laser Turbinates Reduction, Transoral Laser Microsurgery (TLM), Nasal Surgery, and Other Surgery Types], End User (Hospitals and Specialty Clinics, Physician Offices, and Other End Users), and Geography (North America, Europe, Asia Pacific, South and Central America, and Middle East and Africa)
Jun 2022
Mobile Cleanroom Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Softwall and Hardwall), End User (Microelectronics Industry, Pharmaceuticals and Biotechnology Industry, Medical Device Manufacturers, and Others), and Geography
Jun 2022
Ovo-Sexing Technology Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technique (Non-Invasive Imaging, Genetic Editing, Volatile Analysis, Sex Reversal, and Liquid-Based Analysis), End User (Hatcheries and Poultry Farms), and Geography (US, Germany, France, Italy, Spain, Rest of Europe, Israel, and ROW)
Jun 2022
Dental Laser Treatment Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Hard Tissue, Soft Tissue, and Others), End User (Hospitals, Dental Clinics, Dental-Owned Practices, and Others), Clinical Indication [Conservative Dentistry, Root Canal (Endodontic Treatment), Oral Surgery, Implantology, Peri-Implantitis, Periodontics, and Others], and Geography
Jun 2022
Microbiology CRO Services Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Clinical, Medical Device, and Others), Service Type (Assay Development, Custom Viral Stock Production, Microbial Testing, and Others), Microorganisms (Bacteria, Fungi, Viruses, and Parasites), End User (Biotech and Pharmaceutical Companies, Medical Device Companies, and Others), and Geography
Jun 2022
Antimicrobial Surgical Suture Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Triclosan Antimicrobial Suture and Chlorhexidine Antimicrobial Suture), Raw Materials (Polyglactin 910 Antimicrobial Suture, Poliglecaprone 25, and Polyglycolic Acid), Application (Cardiovascular Surgery, General Surgery, Ophthalmic Surgery, Gynecological Surgery, Orthopedic Surgery, Plastic Surgery, Veterinary Surgery, Dental Surgery, and Others), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2022
Fall Management Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Sensor Pads, Floor Mat, Hip Protectors, Alert Systems, Communication Devices, and Other Products), Application (Fall Detection Systems, Fall Prevention Equipment, and Post-Fall Monitoring and Response Systems), Age Group [Elderly Population (65 and Above) and Adults (18–64 years)], End User (Hospitals and Clinics, Nursing Homes, Home Care Settings, and Other End Users), and Geography
Jun 2022
Organoids Services Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Intestine, Liver, Stomach, Pancreas, Lung, Brain, Kidney, and Others), Application (Developmental Biology Disease, Pathology of Infectious Disease, Regenerative Medicine, Drug Toxicity & Efficacy Testing, Drug Discovery & Personalized Medicine, and Others), Source (Pluripotent Stem Cells and Organ Specific Adult Stem Cell), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Get Free Sample For